Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
Financial Results:
Jubilant Ingrevia Ltd reported Revenues for Q3FY24 of ₹966.00 Crores down from ₹1,158.00 Crore year on year, a fall of 16.58%.
Total Expenses for Q3FY24 of ₹920.00 Crores down from ₹1,044.00 Crores year on year, a fall of 11.88%.
Consolidated Net Profit of ₹39.00 Crores down 57.61% from ₹92.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹2.42, down 57.91% from ₹5.75 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.